Ann: Prospectus, page-18

That really surprised me too. Agree with GC. yourself and others. Glad to read the directors have taken up their share of this, that's a positive. I believe in this company's potential; just look at the growth of Epichem, revenue of around a million expected this quarter, and the interest in the MPL trials here and os, but if I said I wasn't upset, I'd be lying. Maybe the execs could show their commitment by cutting their salaries to the minimum wage or even nothing until this difficult phase was through....maybe some kind of deferred pay scheme, the company succeeds and they get their back pay, say with a bonus. It's a joke, but I'm not in much of a joking mood, I'm just a poor little investor.